P3 Health Partners Inc.

PIII

US7444131053

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
0.4462 ^USD	-7.02%		-11.75%	-68.35%

Apr. 01	BTIG Research Downgrades P3 Health Partners to Neutral From Buy	MT
Mar. 28	Transcript : P3 Health Partners Inc., Q4 2023 Earnings Call, Mar 28, 2024

P3 Health Partners Inc. Reaffirms Earnings Guidance for the full-year ending December 31, 2024

March 15, 2024 at 08:00 am EDT

P3 Health Partners Inc. Reaffirmed Earnings Guidance for the full-year ending December 31, 2024. For the year, the company Reaffirming revenue from $1.45 billion to $1.55 billion.

Latest news about P3 Health Partners Inc.

BTIG Research Downgrades P3 Health Partners to Neutral From Buy	Apr. 01	MT
Transcript : P3 Health Partners Inc., Q4 2023 Earnings Call, Mar 28, 2024	Mar. 28
P3 Health Partners Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Earnings Flash (PIII) P3 HEALTH PARTNERS Reports Q4 Revenue $346.9M, vs. Street Est of $302.7M	Mar. 28	MT
P3 Health Partners Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 28	CI
P3 Health Partners Inc. Reaffirms Earnings Guidance for the full-year ending December 31, 2024	Mar. 15	CI
Lake Street Adjusts Price Target on P3 Health Partners to $4.50 From $9, Maintains Buy Rating	Mar. 14	MT
Transcript : P3 Health Partners Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 01:30 PM	Jan. 10
Global markets live: J Sainsbury, Intel, Tesla, Boeing, Amazon...	Jan. 10
P3 Health Partners Reaffirms 2023 Revenue Guidance, Issues 2024 Outlook	Jan. 10	MT
In wait-and-see mode	Jan. 10
P3 Health Partners Inc. Reaffirms Earnings Guidance for the Year Ended December 31, 2023 and Provides Earnings Guidance for the Year Ending December 31, 2024	Jan. 09	CI
Transcript : P3 Health Partners Inc., Q3 2023 Earnings Call, Nov 08, 2023	Nov. 08
Earnings Flash (PIII) P3 HEALTH PARTNERS Posts Q3 Revenue $288.4M, vs. Street Est of $293.3M	Nov. 08	MT
P3 Health Partners Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 08	CI
P3 Health Partners Inc. Provides Earnings Guidance for the Year 2023	Nov. 08	CI
BTIG Initiates P3 Health Partners With Buy Rating, Price Target is $5	23-09-01	MT
Transcript : P3 Health Partners Inc., Q2 2023 Earnings Call, Aug 07, 2023	23-08-07
Earnings Flash (PIII) P3 HEALTH PARTNERS Reports Q2 Revenue $329.1M, vs. Street Est of $303.3M	23-08-07	MT
P3 Health Partners Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-07	CI
P3 Health Partners Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2023	23-08-07	CI
TD Cowen Initiates P3 Health Partners at Market Perform	23-06-30	MT
P3 Health Partners Inc.(NasdaqCM:PIII) dropped from Russell 2500 Value Index	23-06-23	CI
P3 Health Partners Inc.(NasdaqCM:PIII) dropped from Russell Small Cap Comp Value Index	23-06-23	CI
P3 Health Partners Inc.(NasdaqCM:PIII) added to Russell 3000E Index	23-06-23	CI

P3 Health Partners Inc. is a patient-centered and physician-led population health management company. The Company supports primary care providers with value-based care coordination and administrative services that improve patient outcomes and lower costs. Through partnerships with these local providers, it creates an enhanced patient experience by navigating, coordinating, and integrating the patientâs care within the healthcare system. Its technology platform, P3 Technology/Health Hub, enables physicians, care teams, patients and their family members to engage in the care journey. P3 Technology/Health Hub integrates clinical and claims data from more than 250 disparate data points each month from payors, outpatient and inpatient facilities and other ancillary care settings. It has a network of more than 2,800 affiliated primary care providers across the country. Its local teams of health care professionals manage the care of thousands of patients in 23 counties across five states.

Sector

Biotechnology & Medical Research

Calendar

2024-05-07 - Q1 2024 Earnings Release (Projected)

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for P3 Health Partners Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.4462 USD

Average target price

2.7 USD

Spread / Average Target

+505.11%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
P3 HEALTH PARTNERS INC.	-68.35%	53.25M
IQVIA HOLDINGS INC.	+1.51%	42.75B
LONZA GROUP AG	+49.22%	41.61B
MODERNA, INC.	+8.57%	41.34B
CELLTRION, INC.	-12.36%	26.59B
ICON PUBLIC LIMITED COMPANY	+8.92%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-25.13%	18.12B
MEDPACE HOLDINGS, INC.	+29.17%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.12%	11.76B
UNITED THERAPEUTICS CORPORATION	+6.35%	11B

Other Biotechnology & Medical Research